share_log

WuXi AppTec Co., Ltd. (SHSE:603259) Institutional Owners May Be Pleased With Recent Gains After 9.0% Loss Over the Past Year

WuXi AppTec Co., Ltd. (SHSE:603259) Institutional Owners May Be Pleased With Recent Gains After 9.0% Loss Over the Past Year

无锡药明康德有限公司(SHSE: 603259)机构所有者可能对在过去一年亏损9.0%之后最近的涨势感到满意
Simply Wall St ·  2023/01/22 19:35

A look at the shareholders of WuXi AppTec Co., Ltd. (SHSE:603259) can tell us which group is most powerful. We can see that institutions own the lion's share in the company with 41% ownership. Put another way, the group faces the maximum upside potential (or downside risk).

看看药明康德股份有限公司(上交所股票代码:603259)的股东,我们就知道哪个集团最有权势。我们可以看到,机构拥有该公司最大的份额,拥有41%的股权。换句话说,该集团面临着最大的上行潜力(或下行风险)。

Last week's CN¥19b market cap gain would probably be appreciated by institutional investors, especially after a year of 9.0% losses.

上周人民币190亿元的市值增长可能会受到机构投资者的赞赏,尤其是在经历了9.0%的亏损之后。

Let's take a closer look to see what the different types of shareholders can tell us about WuXi AppTec.

让我们仔细看看不同类型的股东能告诉我们关于药明康德的什么。

See our latest analysis for WuXi AppTec

参见我们对药明康德的最新分析

ownership-breakdown
SHSE:603259 Ownership Breakdown January 23rd 2023
上海证交所:603259所有权明细2023年1月23日

What Does The Institutional Ownership Tell Us About WuXi AppTec?

关于药明康德,机构所有制告诉了我们什么?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

机构通常在向自己的投资者报告时,以基准来衡量自己,因此一旦一只股票被纳入主要指数,它们往往会对这只股票变得更加热情。我们预计,大多数公司都会有一些机构登记在册,特别是在它们正在增长的情况下。

As you can see, institutional investors have a fair amount of stake in WuXi AppTec. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at WuXi AppTec's earnings history below. Of course, the future is what really matters.

如你所见,机构投资者对药明康德持有相当多的股份。这意味着为这些机构工作的分析师已经看过了这只股票,他们喜欢它。但就像其他人一样,他们也可能错了。如果多家机构同时改变对一只股票的看法,你可能会看到股价迅速下跌。因此,下面药明康德的收入历史值得一看。当然,未来才是真正重要的。

earnings-and-revenue-growth
SHSE:603259 Earnings and Revenue Growth January 23rd 2023
上海证交所:603259收益和收入增长2023年1月23日

Hedge funds don't have many shares in WuXi AppTec. With a 7.2% stake, CEO Ge Li is the largest shareholder. For context, the second largest shareholder holds about 5.4% of the shares outstanding, followed by an ownership of 4.7% by the third-largest shareholder.

对冲基金对药明康德的持股并不多。首席执行官葛Li持有该公司7.2%的股份,是其最大股东。作为参考,第二大股东持有约5.4%的流通股,第三大股东持有4.7%的股份。

A closer look at our ownership figures suggests that the top 22 shareholders have a combined ownership of 50% implying that no single shareholder has a majority.

仔细观察我们的持股数据就会发现,前22名股东总共拥有50%的股份,这意味着没有单一股东拥有多数股权。

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

研究机构持股是衡量和筛选股票预期表现的好方法。通过研究分析师的情绪,也可以达到同样的效果。有相当数量的分析师追踪该股,因此了解他们对未来的总体看法可能是有用的。

Insider Ownership Of WuXi AppTec

药明康德的内部人所有权

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

尽管对内部人的准确定义可能是主观的,但几乎每个人都认为董事会成员是内部人。公司管理层对董事会负责,董事会应代表股东的利益。值得注意的是,有时最高层管理人员本身也是董事会成员。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

内部人持股是积极的,当它标志着领导层像公司的真正所有者一样思考时。然而,高内部人持股也可以给公司内部的一个小团体带来巨大的权力。在某些情况下,这可能是负面的。

We can report that insiders do own shares in WuXi AppTec Co., Ltd.. The insiders have a meaningful stake worth CN¥21b. Most would say this shows a good alignment of interests between shareholders and the board. Still, it might be worth checking if those insiders have been selling.

我们可以报告,内部人士确实持有药明康德股份有限公司的股份。内部人士持有价值210亿元人民币的可观股份。大多数人会说,这表明股东和董事会之间的利益得到了很好的一致。不过,这些内部人士是否一直在抛售股票,或许值得一查。

General Public Ownership

一般公有制

The general public-- including retail investors -- own 32% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

包括散户投资者在内的普通公众持有该公司32%的股份,因此不能轻易忽视。这种规模的所有权虽然可观,但如果决策与其他大股东不同步,可能不足以改变公司政策。

Private Equity Ownership

私募股权所有权

Private equity firms hold a 5.4% stake in WuXi AppTec. This suggests they can be influential in key policy decisions. Sometimes we see private equity stick around for the long term, but generally speaking they have a shorter investment horizon and -- as the name suggests -- don't invest in public companies much. After some time they may look to sell and redeploy capital elsewhere.

私募股权公司持有药明康德5.4%的股份。这表明,他们可以在关键的政策决策中发挥影响力。有时我们会看到私募股权投资长期存在,但总的来说,它们的投资期限较短,而且--顾名思义--不会对上市公司进行太多投资。一段时间后,他们可能会考虑出售并将资本重新配置到其他地方。

Private Company Ownership

私营公司所有权

We can see that Private Companies own 15%, of the shares on issue. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

我们可以看到,私营公司拥有15%的已发行股份。或许有必要对此进行更深入的研究。如果关联方,如内部人士,对这些私营公司中的一家有利害关系,则应在年报中披露。私营公司也可能对该公司拥有战略利益。

Next Steps:

接下来的步骤:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. For instance, we've identified 3 warning signs for WuXi AppTec (1 doesn't sit too well with us) that you should be aware of.

我发现看看到底是谁拥有一家公司是非常有趣的。但为了真正获得洞察力,我们还需要考虑其他信息。例如,我们已经确定药明康德的3个警示标志(1对我们来说不太合适),这一点你应该知道。

If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

如果你像我一样,你可能会想一想这家公司是会增长还是会萎缩。幸运的是,您可以查看这份显示分析师对其未来预测的免费报告。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的数字是使用过去12个月的数据计算的,指的是截至财务报表日期的最后一个月的12个月期间。这可能与全年的年度报告数字不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发